Frederick G. Vogt

2019

In 2019, Frederick G. Vogt earned a total compensation of $2M as General Counsel and Corporate Secretary at Lion Biotechnologies, a 303% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$160,000
Option Awards$1,453,980
Salary$400,000
Other$11,200
Total$2,025,180

Vogt received $1.5M in option awards, accounting for 72% of the total pay in 2019.

Vogt also received $160K in non-equity incentive plan, $400K in salary and $11.2K in other compensation.

Rankings

In 2019, Frederick G. Vogt's compensation ranked 5,857th out of 13,971 executives tracked by ExecPay. In other words, Vogt earned more than 58.1% of executives.

ClassificationRankingPercentile
All
5,857
out of 13,971
58th
Division
Manufacturing
2,198
out of 5,701
61st
Major group
Chemicals And Allied Products
795
out of 2,200
64th
Industry group
Drugs
670
out of 1,886
65th
Industry
Biological Products, Except Diagnostic Substances
159
out of 389
59th
Source: SEC filing on April 27, 2021.

Vogt's colleagues

We found three more compensation records of executives who worked with Frederick G. Vogt at Lion Biotechnologies in 2019.

2019

Maria Fardis

Lion Biotechnologies

Chief Executive Officer

2019

Friedrich Finckenstein

Lion Biotechnologies

Chief Medical Officer

2019

Timothy Morris

Lion Biotechnologies

Chief Financial Officer

News

In-depth

You may also like